PL
EN
Jerzy Starak
Founder and Owner Polpharma Biologics Group
Jerzy Starak is one of the Polish entrepreneurs whose activities contributed to the modernization and innovative development of the Polish economy. A visionary full of courage and determination in realizing ever new business challenges.
Jerzy Starak played a key role in the development of the Polish pharmaceutical sector. In 2000, he became the owner of Polpharma S.A. Ambitious modernization processes, huge investments in research and laboratory infrastructure and cooperation with top class specialists made Polpharma S.A. a European leader in the production of generic drugs.
In 2010, Jerzy Starak, inspired by the global direction in pharmaceutical development, made the decision to expand his business activities into production of biological drugs. Already in 2012, the first Research and Development Center opened in the Gdańsk Science and Technology Park and in 2020 another modern Center for Development and Production on an industrial scale began its activities in Warsaw-Duchnice. Today, Polpharma Biologics is the largest biosimilar drug development company in this part of Europe, operating in partnerships with global leaders in the pharmaceutical market.
“We are experts in managing projects, transparent communicators and always deliver on our commitments”
Chairman, Polpharma Biologics Group
“We are passionate about getting safe and effective medicines to patients”
Vice Chairman, Polpharma Biologics Group
“We value everyone equally and always treat each other with respect”
Supervisory Board Member, Polpharma Biologics Group
“We care about being respectful and transparent”
Supervisory Board Member, Polpharma Biologics Group
“We work with dedication and find innovative solutions”
Supervisory Board Member, Polpharma Biologics Group
“We care about being respectful and transparent”
CEO, Polpharma Biologics Group
"We like to collaborate and can rely on each other"
President of the Management Board (WAW and GDS), Polpharma Biologics Group
“We work with dedication and find innovative solutions”
Chief Technical Officer, Polpharma Biologics Group
"We care about delivering on our commitments"
Chief Business Officer, Polpharma Biologics Group
“We are experts in managing projects, transparent communicators and always deliver on our commitments”
Chief Development Officer, Polpharma Biologics Group
“Our patients expect and deserve high quality and innovative medicines”
Chief Quality Officer, Polpharma Biologics Group
“We are passionate about getting safe and effective medicines to patients”
Chief Financial Officer, Polpharma Biologics Group
“We value everyone equally and always treat each other with respect ”
VP P&O, Polpharma Biologics Group
“We care about being respectful and transparent”
General Counsel, Polpharma Biologics Group
“We work with dedication and find innovative solutions”
Site Head, Polpharma Biologics Gdańsk
"We like to collaborate and can rely on each other"
Site Head, Polpharma Biologics Warsaw
“We anticipate potential issues before they arise, always ensuring high quality outcomes”
Site Head, Polpharma Biologics Utrecht
